Urogen Pharma (URGN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov7

UroGen Pharma Reports Q3 Results and Launches ZUSDURI

05:57

Nov6

Urogen Pharma released FY2025 Q3 earnings on November 6 Pre-Market (EST), actual revenue USD 27.48 M (forecast USD 32.47 M), actual EPS USD -0.6938 (forecast USD -0.68)

14:30

Urogen Pharma released FY2025 9-month earnings on November 6 Pre-Market EST, actual revenue USD 71.95 M, actual EPS USD -2.6645

14:30

UroGen Pharmaceuticals Reports Preliminary Results of UGN-103 Clinical Trial

12:58

Oct30

Urogen Pharma to Release FY2025 Q3 Earnings on November 6 Pre-Market EST, Forecast Revenue USD 32.47 M, EPS USD -0.6928

00:08

Oct24

Gershell covers healthcare stocks and gives Urogen Pharma target price

13:32

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 27.48 M, Net Income -33.35 M, EPS -0.6938

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 24.22 M, Net Income -49.94 M, EPS -1.046

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 20.25 M, Net Income -43.84 M, EPS -0.9245

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change